摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5S,7R,8R,9S,10S,13R,14S,17R)-7-羟基-17-((2R,5R)-5 | 301695-61-4

中文名称
(5S,7R,8R,9S,10S,13R,14S,17R)-7-羟基-17-((2R,5R)-5
中文别名
(5S,7R,8R,9S,10S,13R,14S,17R)-7-羟基-17 - ((2R,5R)-5
英文名称
(5α,7α,24R)-7,24-dihydroxycholestan-3-one
英文别名
7α,24R-dixydroxy-5α-cholestane-3-one;(5α,7α,24R)-7,24-dihydroxy-3-ketocholestane;7α,24R-dihydroxy-5αH-cholestan-3-one;Cholestan-3-one, 7,24-dihydroxy-, (5a,7a,24R)-;(5S,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-17-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
(5S,7R,8R,9S,10S,13R,14S,17R)-7-羟基-17-((2R,5R)-5化学式
CAS
301695-61-4
化学式
C27H46O3
mdl
——
分子量
418.66
InChiKey
FGKQZAUZOBFLBY-GGBHDQTRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.96
  • 拓扑面积:
    57.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME
    申请人:Enterin, Inc.
    公开号:US20200262864A1
    公开(公告)日:2020-08-20
    Described are deuterated forms of aminosterols, or a pharmaceutically acceptable salt thereof, wherein one or more hydrogen atoms at one or more positions selected from C1, C2, C3, C4, C5, C6, C7, C8, C9, C11, C12, C14, C15, C16, C17, C18, C19, C20, C21, C22, C23, C24, C25, C26, and C27, are replaced with deuterium.
    描述了氨基固醇的氘代形式,或其药用可接受盐,其中在C1、C2、C3、C4、C5、C6、C7、C8、C9、C11、C12、C14、C15、C16、C17、C18、C19、C20、C21、C22、C23、C24、C25、C26和C27中的一个或多个位置上的一个或多个氢原子被氘取代。
  • A Concise and Stereoselective Synthesis of Squalamine
    作者:Dong-Hui Zhang、Feng Cai、Xiang-Dong Zhou、Wei-Shan Zhou
    DOI:10.1021/ol035062j
    日期:2003.9.1
    [reaction: see text] A short and highly stereoselective synthesis of the novel steroid squalamine (1) was accomplished in nine steps from easily available methyl chenodeoxylcholanate 2. Our synthesis featured improved dehydrogenation of 4 followed by conjugate reduction to construct the trans AB-ring system and efficient asymmetric isopropylation of aldehyde 6 to introduce the C-24R-hydroxyl group
    [反应:参见文本]从易于获得的甲基鹅去氧胆酸甲酯2的九步中完成了新型甾体角鲨胺(1)的短而高度立体选择性的合成。我们的合成具有改善的4脱氢率,然后偶联物还原以构建反式AB环的特点。系统和醛6的有效不对称异丙基化以引入C-24R-羟基。
  • A new highly stereoselective construction of the sidechain of squalamine through improved Sharpless catalytic asymmetric dihydroxylation
    作者:Xiang-Dong Zhou、Feng Cai、Wei-Shan Zhou
    DOI:10.1016/s0040-4039(01)00191-5
    日期:2001.3
    A new highly stereoselective construction of the sidechain of squalamine has been achieved by using methyl-3-keto-5α-chenodeoxycholanate (2) as the starting material and an improved Sharpless catalytic asymmetric dihydroxylation as the key step.
    角鲨胺侧链的一种新的高度立体选择性的结构已经通过使用3-keto-5α-chenodeoxycholanate甲基(2)作为起始材料,并改进了Sharpless催化不对称二羟基化作为关键步骤。
  • Formal Synthesis of Squalamine from Desmosterol
    作者:Kazuo Okumura、Yutaka Nakamura、Seiji Takeuchi、Isao Kato、Yoshinori Fujimoto、Nobuo Ikekawa
    DOI:10.1248/cpb.51.1177
    日期:——
    The key intermediate to squalamine, (5α,7α,24R)-7,24-dihydroxy-cholestan-3-one, was synthesized from the 3-O-acetyl-24R,25-dihydroxy derivative of desmosterol via 10 steps in 16% overall yield and squalamine was also prepared via two further steps in 7.4% total yield from the desmosterol derivative.
    角鲨胺的关键中间体(5α,7α,24R)-7,24-二羟基胆甾坦-3-酮是由去莫甾醇的3-O-乙酰基-24R,25-二羟基衍生物经10步合成,浓度为16%总产率和角鲨胺还通过另外两个步骤由去莫甾醇衍生物制备,总产率为 7.4%。
  • Engineered biocatalysts and methods for synthesizing chiral amines
    申请人:Codexis, Inc.
    公开号:US11034939B2
    公开(公告)日:2021-06-15
    The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.
    本公开提供了用于生产胺的工程化转氨酶多肽、编码工程化转氨酶的多核苷酸、能够表达工程化转氨酶的宿主细胞,以及使用工程化转氨酶制备用于生产活性药剂的化合物的方法。
查看更多